DIECI, MARIA VITTORIA
DIECI, MARIA VITTORIA
Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management
2008 Guarneri, Valentina; Giovannelli, S; Ficarra, G; Bettelli, S; Maiorana, A; Piacentini, F; Barbieri, E; Dieci, MARIA VITTORIA; D'Amico, R; Jovic, G; Conte, Pierfranco
Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer.
2010 Guarneri, Valentina; Barbieri, E; Dieci, MARIA VITTORIA; Piacentini, F; Conte, Pierfranco
Survival in Hormone Receptor Positive/HER2 Negative Breast Cancer Patients Treated with Preoperative Chemotherapy.
2010 Barbieri, E; Piacentini, F; Dieci, MARIA VITTORIA; Ficarra, G; Conte, Pierfranco; Guarneri, V.
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts
2011 Barbieri, E; Piacentini, F; Dieci, MARIA VITTORIA; Ficarra, G; Bettelli, S; Conte, Pierfranco; Guarneri, V.
Timing for starting second line therapy in recurrent ovarian cancer.
2011 Guarneri, Valentina; Barbieri, E; Dieci, MARIA VITTORIA; Piacentini, F; Conte, Pierfranco
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer
2011 Guarneri, Valentina; Pecchi, A; Piacentini, F; Barbieri, E; Dieci, MARIA VITTORIA; Ficarra, G; Tazzioli, G; Frassoldati, A; Battista, R; Canossi, B; Mauri, C; D'Amico, R; Conte, Pierfranco; Torricelli, P.
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis
2012 Dieci, MARIA VITTORIA; E., Barbieri; S., Bettelli; F., Piacentini; C., Omarini; G., Ficarra; S., Balduzzi; M., Dominici; Conte, Pierfranco; Guarneri, Valentina
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer
2012 Guarneri, Valentina; E., Barbieri; F., Piacentini; Dieci, MARIA VITTORIA; C., Omarini; G., Ficarra; S. R., Bettelli; Conte, Pierfranco
Tumori ginecologici
2012 Conte, Pierfranco; E., Barbieri; Guarneri, Valentina; F., Piacentini; Dieci, MARIA VITTORIA
Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer.
2012 Guarneri, Valentina; Dieci, MARIA VITTORIA; Conte, Pierfranco
Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma
2012 M., Maur; C., Tomasello; A., Frassoldati; Dieci, MARIA VITTORIA; E., Barbieri; Conte, Pierfranco
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis
2013 Dieci, MARIA VITTORIA; Barbieri, E; Piacentini, F; Ficarra, G; Bettelli, S; Dominici, M; Conte, Pierfranco; Guarneri, Valentina
Quantification of residual risk of relapse in breast cancer patients optimally treated
2013 Dieci, MARIA VITTORIA; M., Arnedos; S., Delaloge; F., Andre
The Future of Chemotherapy in the Era of Personalized Medicine
2013 Dieci, MARIA VITTORIA; Guarneri, Valentina; Conte, Pierfranco
Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives
2013 Dieci, MARIA VITTORIA; M., Arnedos; F., Andre; J. C., Soria
Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers
2013 S., Alsafadi; C., Even; C., Falet; A., Goubar; F., Commo; V., Scott; V., Quidville; L., Albiges; Dieci, MARIA VITTORIA; J., Guegan; V., Lazar; J. C., Ahomadegbe; S., Delaloge; F., André
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients.
2013 Guarneri, Valentina; Dieci, MARIA VITTORIA; Barbieri, E; Piacentini, F; Omarini, C; Ficarra, G; Bettelli, S; Conte, Pierfranco
Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer
2013 F., Andre; Dieci, MARIA VITTORIA; P., Dubsky; C., Sotiriou; G., Curigliano; C., Denkert; S., Loi
Targeting the Fibroblast Growth Factor Receptor Pathway in Human Cancer
2013 Dieci, MARIA VITTORIA; Andre, F.
New strategies to overcome resistance to mammalian target of rapamycin inhibitors in breast cancer
2013 C., Vicier; Dieci, MARIA VITTORIA; F., Andre